Predictive Factors for Poor Outcome following Chemonucleolysis with Condoliase in Lumbar Disc Herniation

Background and Objectives: Condoliase, a chondroitin sulfate ABC endolyase, is a novel and minimally invasive chemonucleolytic drug for lumbar disc herniation. Despite the growing number of treatments for lumbar disc herniation, the predicting factors for poor outcomes following treatment remain unc...

Descripción completa

Detalles Bibliográficos
Autores principales: Takeuchi, Shu, Hanakita, Junya, Takahashi, Toshiyuki, Inoue, Tomoo, Minami, Manabu, Suda, Izumi, Nakamura, Sho, Kanematsu, Ryo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9781337/
https://www.ncbi.nlm.nih.gov/pubmed/36557070
http://dx.doi.org/10.3390/medicina58121868

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9781337/
https://www.ncbi.nlm.nih.gov/pubmed/36557070
http://dx.doi.org/10.3390/medicina58121868

Ejemplares similares